首頁 › 瀰漫性硬皮症 › 紐約州 › New York City
New York City, NY 的 瀰漫性硬皮症 臨床試驗
8 項針對 瀰漫性硬皮症 的研究正在 New York City（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
招募中2 期
- Hospital for Special Surgery, New York
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
招募中1 期
- Icahn School of Medicine at Mount Sinai, New York
A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
招募中3 期
- GSK Investigational Site, New York
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
招募中2/3 期
- GSK Investigational Site, New York
- GSK Investigational Site, New York
Platform Clinical Study for Conquering Scleroderma
招募中2 期
- Hospital for Special Surgery, New York
- Columbia University Medical Center, New York
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
招募中2/3 期
- Columbia University Irving Medical Center, New York
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
招募中1/2 期
- Nkarta Investigational Site, New York
Scleroderma Registry & Repository at the Hospital for Special Surgery
招募中觀察性研究歡迎健康志工
- Hospital for Special Surgery, New York
其他城市的 瀰漫性硬皮症 試驗
- Ann Arbor, MI7 項研究
- Chicago, IL7 項研究
- Durham, NC6 項研究
- Los Angeles, CA6 項研究
- Houston, TX5 項研究
- Boston, MA5 項研究
- Baltimore, MD5 項研究
- New Orleans, LA4 項研究
- Pittsburgh, PA4 項研究
- Kansas City, KS4 項研究
- Philadelphia, PA4 項研究
- Dallas, TX3 項研究
New York City 的其他研究
- 乳癌134 項研究
- 非小細胞肺癌120 項研究
- 癌症（所有類型）110 項研究
- 前列腺癌103 項研究
- 轉移性癌症93 項研究
- 大腸直腸癌77 項研究
- 卵巢癌69 項研究
- 肺癌60 項研究
- 胰臟癌60 項研究
- 多發性骨髓瘤60 項研究
- 子宮內膜癌52 項研究
- 心臟衰竭51 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。